MRK Merck & Co., Inc.

NYSE
$135.84

Merck & Co., Inc. (MRK) is expected to report earnings on November 3, 2026, before the market open. The consensus earnings estimate is $2.27 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.7% since its last earnings release on August 4, 2026.

Merck & Co. Beat Expectations, Guides In-line
Tuesday, August 4, 2026 · 6:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 3
Tuesday · 6:30 AM ET
Earnings Whisper
-
vs $2.27
Rev est $17.5B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $130.86

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Merck & Co., Inc.

Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products.

Sector

Healthcare

Industry

Drug Manufacturers / Major